Nilo Therapeutics
Mapping the brain-body axis to achieve proper immune balance
Moleculo’s founders developed new library prep and analysis techniques that allowed them to assemble short sequences of DNA base-pair information into accurate, synthetic long reads. Illumina acquired the company in 2013.
Mapping the brain-body axis to achieve proper immune balance
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors